Literature DB >> 11132157

The mouse Kell blood group gene (Kel): cDNA sequence, genomic organization, expression, and enzymatic function.

S Lee1, D C Russo, J Pu, M Ho, C M Redman.   

Abstract

The human Kell blood group system is important in transfusion medicine, since Kell is a polymorphic protein and some of its antigens can cause severe reactions if mismatched blood is transfused, while maternal alloimmunization may lead to fetal and neonatal anemia. In humans, Kell is an Mr 93,000 type II membrane glycoprotein with endothelin-3-converting enzyme activity that is linked by a single disulfide bond to another protein, XK, that spans the membrane ten times. An absence of XK leads to clinical symptoms termed the McLeod syndrome. We determined the cDNA sequence of the mouse Kell homologue, the organization of the gene, expression of the protein and its enzymatic function on red cells. Comparison of human and mouse Kell cDNA showed 80% nucleotide and 74% amino acid sequence identity. Notable differences are that the mouse Kell protein has eight probable N-linked carbohydrate side chains, compared to five for human Kell, and that the mouse homologue has one more extracellular cysteine than human Kell protein. The mouse Kell gene (Kel), like its human counterpart, is similarly organized into 19 exons. Kel was located to proximal Chromosome 6. Northern blot analysis showed high expression in spleen and weaker levels in testis and heart. Western blot analysis of red cell membrane proteins demonstrated that mouse Kell glycoprotein has an apparent Mr of 110,000 and, on removal of N-linked sugars, 80,000. As in human red cells, Kell is disulfide-linked to XK and mouse red cells have endothelin-3-converting enzyme activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11132157     DOI: 10.1007/s002510000251

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  6 in total

1.  Giant axon formation in mice lacking Kell, XK, or Kell and XK: animal models of McLeod neuroacanthocytosis syndrome.

Authors:  Xiang Zhu; Eun-Sook Cho; Quan Sha; Jianbin Peng; Yelena Oksov; Siok Yuen Kam; Mengfatt Ho; Ruth H Walker; Soohee Lee
Journal:  Am J Pathol       Date:  2014-01-07       Impact factor: 4.307

2.  Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies.

Authors:  Sean R Stowell; Kathryn R Girard-Pierce; Nicole H Smith; Kate L Henry; C Maridith Arthur; James C Zimring; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2013-04-29       Impact factor: 3.157

3.  Spontaneously arising red cells with a McLeod-like phenotype in normal donors.

Authors:  David J Araten; Katie J Sanders; Jeffrey Pu; Soohee Lee
Journal:  Mutat Res       Date:  2009-04-02       Impact factor: 2.433

4.  Multiple loci are linked with anti-red blood cell antibody production in NZB mice -- comparison with other phenotypes implies complex modes of action.

Authors:  N J Lee; R J Rigby; H Gill; J J Boyle; L Fossati-Jimack; B J Morley; T J Vyse
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

5.  Ablation of the Kell/Xk complex alters erythrocyte divalent cation homeostasis.

Authors:  Alicia Rivera; Siok Yuen Kam; Mengfatt Ho; Jose R Romero; Soohee Lee
Journal:  Blood Cells Mol Dis       Date:  2012-10-31       Impact factor: 3.039

6.  IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice.

Authors:  Paurvi Shinde; Heather L Howie; Tamara C Stegmann; Ariel M Hay; Hayley R Waterman; Zoltan Szittner; Arthur E H Bentlage; Linda Kapp; Suzanne N Lissenberg-Thunnissen; Gillian Dekkers; Richard B M Schasfoort; Sarah J Ratcliffe; Mark E Smolkin; Gestur Vidarsson; C Ellen van der Schoot; Krystalyn E Hudson; James C Zimring
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.